Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response.
about
Biological, clinical, and ethical advances of placebo effects.Network modulation following sham surgery in Parkinson's disease.A brain network response to sham surgery.How placebos change the patient's brain.Placebo mechanisms across different conditions: from the clinical setting to physical performanceMechanisms and clinical implications of the placebo effect: is there a potential for the elderly? A mini-review.Bursting activity of substantia nigra pars reticulata neurons in mouse parkinsonism in awake and anesthetized states.Mind matters: placebo enhances reward learning in Parkinson's disease.Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?Highlights from the 2013 Science of Placebo thematic workshopPlacebo and the new physiology of the doctor-patient relationship.Placebo response in pain, fatigue, and performance: Possible implications for neuromuscular disorders.Problematic placebos in physical therapy trials.Teaching neurons to respond to placebos.Chronic dopamine depletion augments the functional expression of K-ATP channels in the rat subthalamic nucleus.AMP kinase regulates K-ATP currents evoked by NMDA receptor stimulation in rat subthalamic nucleus neurons.The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning.Deep brain stimulation of the substantia nigra pars reticulata improves forelimb akinesia in the hemiparkinsonian rat.Regulation of polysynaptic subthalamonigral transmission by D2, D3 and D4 dopamine receptors in rat brain slices.
P2860
Q33703954-AFF848CE-3B6A-45FE-B701-49E6BD3E3870Q33944241-B0C2FC63-7C99-44A9-8908-88D879D6FE88Q33944301-C27F6C53-FDFA-47E6-8EDA-5BD06F5FCBE4Q34123529-CBA769F2-7046-4BB2-8262-8ED217476779Q35088465-DAE3224C-B349-4663-AE95-F1847AB3E9E2Q35089955-341BD7BF-ADCB-44EF-A758-DC7390AAE10DQ35526434-280F573D-2A45-40B4-96A1-92CBAE62830CQ35854824-013981EF-3694-4854-992F-ABB265460B0CQ36119267-E780C632-3F53-434A-A036-B5BB224C2C65Q37141569-DFAB89EE-B2C9-4C96-9ADD-75BAC4D6B88FQ37655894-EE6ADEDF-80C7-4F0E-BCE9-BB9FFA84E496Q38935410-16C9CF61-536A-4459-9F0D-2FFBC71E6E7CQ39708679-E4DE8574-817D-45AB-9AA3-EE8C9E4F34E3Q40009826-548A0648-1652-4D7A-A510-14DB86B91136Q42081785-B3313400-20AC-4ACB-805D-AB25C3BFB3E0Q42736652-26E73934-F4F6-409E-B5D2-641596835F71Q48088458-0E935626-FEA9-48B5-8D9A-4908A7A29304Q48332145-229BC71D-8C1E-46D3-AF21-3913013AAD07Q48637788-57ADA71A-6F5F-481A-B20B-C0CADA76EF6B
P2860
Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Electrophysiological propertie ...... parkinsonian placebo response.
@en
Electrophysiological propertie ...... parkinsonian placebo response.
@nl
type
label
Electrophysiological propertie ...... parkinsonian placebo response.
@en
Electrophysiological propertie ...... parkinsonian placebo response.
@nl
prefLabel
Electrophysiological propertie ...... parkinsonian placebo response.
@en
Electrophysiological propertie ...... parkinsonian placebo response.
@nl
P2860
P50
P921
P1476
Electrophysiological propertie ...... parkinsonian placebo response.
@en
P2093
Alessandro Ducati
Fabrizio Benedetti
P2860
P304
P356
10.1113/JPHYSIOL.2009.169425
P407
P577
2009-06-22T00:00:00Z